The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Share News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Gunsynd invests; AQRU launches crypto-backed loans

Tue, 25th Oct 2022 14:53

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Sunrise Resources PLC - Macclesfield, England-based mineral project developer - Says Tolsa USA Inc receives approval for proposed trenching programme at Sunrise's Pioche Sepiolite project in Nevada from the US Bureau of Land Management. The reclamation bond has been submitted, and now up to two kilometres of excavator trenching is due to start this week. This will "better expose and sample" sepiolite deposits. Tolsa is the US subsidiary of Tolsa SA. Tolsa was granted a six-month option to purchase the Pioche project for USD1.3 million back in June and would pay a 3% royalty to Sunrise. The option is extendable for another 12 months upon payment of USD50,000 to Sunrise. Sunrise notes its focus remains on the CS and Hazen pozzolan projects, but Pioche is an example of its strategy to "identify overlooked mineral opportunities" to convert into cash and free carried royalty interests, "such as those the company already holds on the Junction, Garfield and Stonewall exploration projects".

----------

Georgia Capital PLC - Tbilisi, Georgia-based investor in businesses in Georgia - Announces results of its tender offer for outstanding USD365.0 million 6.125% notes due 2024 for cash. Aggregate principal amount of notes accepted for purchase is USD29.2 million, which it intends to cancel. Georgia Capital also will cancel another USD35.8 million in notes that it already owns, leaving USD300.0 million notes outstanding.

----------

Kavango Resources PLC - London-based mineral explorer focused on Botswana - Agrees to raise GBP500,000 from the issue of 27.8 million shares at 1.8 pence each. The shares will be conditionally issued via a direct subscription by a single strategic investor, Arigo Capital Ltd. Follows Monday's GBP3 million equity fundraise to put towards its plans in Botswana. "We are now extremely well positioned to pursue our ambition of making multiple major metal discoveries in Botswana," says CEO Ben Turney.

----------

Gunsynd PLC - London-based investment company focused on the natural resources, life sciences & alcohol sector - Invests AUD90,000, around GBP50,000, into Omega Oil & Gas Ltd. Omega is an Sydney-listed natural gas explorer and oil producer that began trading on the Australian Stock Exchange on Tuesday. It raised AUD15.1 million via the issue of 75.3 million shares at AUD0.20 each. Gunsynd subscribed for 450,000 shares at that price, now holding a 0.4% stake. Omega holds two exploration permits and a petroleum licence in the Surat-Bowen Basin in South-East Queensland, Australia. For the financial year that ended June 30, Omega recorded insubstantial revenue and a loss of AUD2.0 million.

----------

Deltic Energy PLC - AIM-listed natural resources investing company - Says the operator of the licence P2252, Shell UK Ltd, indicates that it is preparing to move the Maersk Resilient drilling rig to the Pensacola location, with mobilisation planned to occur in early November. Drilling is expected to start in mid-November, at which point Deltic will update further.

----------

Cloudbreak Discovery PLC - Vancouver, Canada-based natural resource project generator - Elects to draw GBP203,500 from its GBP10 million equity drawdown agreement with Crescita Capital LLC, into which it had entered last February. Accordingly, 18.5 million Clouadbreak shares are issued at 1.1p each. "The capital drawn down will be used to advance the company's acquisitions of energy royalties, lithium assets and bauxite projects globally," the company explains.

----------

Lamprell PLC - United Arab Emirates-based provider of oil field services - Confirms its London Main Market listing was cancelled as of Tuesday's market open. Shareholders had approved the delisting back in September.

----------

Gaming Realms PLC - London-based developer and licensor of mobile-focused gaming content - Officially launches its content in the US state of Connecticut, alongside its partner DraftKings Inc. Five games are now live, with a further nine to follow shortly. "Users will be able to play some of the company's top titles including Lucky Larry's Lobstermania Slingo, Blackjack X-Change, and our collaboration with the American Cancer Society - Slingo Gems," it says. Notes the US is a "significant" growth market for the firm, and it has a "number" of new operator launches planned.

----------

Ingenta PLC - Oxford, England-based provider of software and services to the publishing industry - Proposes tender offer to purchase 1.8 million shares at 115p each, which is around 11% of its issued share capital. Will have a general meeting on November 11.

----------

Kefi Gold & Copper PLC - Cyprus-based gold and copper exploration and development company with projects in Ethiopia and Saudi Arabia - Updates on its third quarter operations. At Tulu Kapi gold project in Ethiopia, says project costs were updated by suppliers, and it accommodated a 7% increase to capital requirements to USD320 million within the planned syndicate. Estimates that cash from the project in the first two years will be sufficient to repay debt. Earnings before interest, tax, depreciation and amortisation will average USD127 million annually in the first seven years, with USD89 million for Kefi's interest. Also plans to re-commence exploration of additional projects within Tulu Kapi district exploration area. Meanwhile, in Saudi Arabia, says its activities have benefited from the Saudi government's push to bring in international expertise and fast-track growth in the mining sector. Notes rapid progress in the quarter. "Going forward the company's Saudi assets are expected to have shorter gestation, approval, financing and development schedules," Kefi says.

----------

AQRU PLC - London-based incubator for decentralised finance businesses - Launches 'BlockLender', 'a start-up that offers cryptocurrency-collateralised lending services. BlockLender will enable digital assets-holders to access instant loans, using their cryptocurrency as collateral, starting from a minimum value of USD100. "While crypto-backed loans enable customers to use their digital assets to make real-life purchases, many providers have taken on excessive levels of risk with people's assets, without their customers knowing. With the launch of BlockLender, AQRU is bringing much-needed transparency to the evolving digital asset lending market," says CEO Philip Blows, who also will be managing director at BlockLender.

----------

Open Orphan PLC - London-based research organisation testing infectious and respiratory disease products - Confirms its name change to hVIVO PLC will take effect from Wednesday. The firm previously explained it will take on the moniker of its clinical research subsidiary, and said the name change will better reflect its core human challenge and early clinical services business.

----------

MGC Pharmaceuticals - Perth, Australia-based medicinal cannabis company - Announces results of open label clinical study, for a white label version of ArtemiC Support. The study was conducted on 60 Covid-vaccinated participants in Spain who were suffering from post-acute Covid, also known as long Covid. The nutraceutical was administered in 10 drops twice a day for six weeks, and proved to alleviate symptoms of the long Covid, which relate to functional limitations. These include pain, mental confusion, sleep disorders, and inflammation. "The biological markers in the blood tests further proved a reduction of inflammation and enterohepatic involvement, as well as liver reactant proteins," it explains. "The clinical study has demonstrated that MGC Pharma's ArtemiC Rescue formulation has markedly affected outward symptoms of Long-COVID, which is an excellent step forward in progressing the clinical proof of the benefits of ArtemiC," says Co-Founder & Managing Director Roby Zomer.

----------

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
3 Feb 2023 11:01

MGC receives USD600,000 funding; changes chief financial officer

(Alliance News) - MGC Pharmaceuticals Ltd on Friday said it received USD600,000 in funding provided by Mercer Street Capital Partners LLC, while it has appointed a new chief financial officer.

Read more
2 Feb 2023 19:39

TRADING UPDATES: Lords sells business; Atome wins joint venture deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 Jan 2023 16:23

TRADING UPDATES: DP Eurasia annual sales grow despite Russia decline

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
11 Jan 2023 09:30

CORRECT: Getech signs deal; AfriTin confirms name change

(Corrects that Zenith Energy is based in Canada, not in Scotland.)

Read more
10 Jan 2023 21:34

TRADING UPDATES: Getech signs deal; AfriTin confirms name change

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
3 Jan 2023 17:17

TRADING UPDATES: MGC cuts costs; Ince gets Arden sale green light

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
28 Dec 2022 09:45

IN BRIEF: MGC Pharma receives AUD800,000 funding from Mercer Street

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Secures AUD800,000 in funding under USD10 million convertible securities financing facility agreement signed with Mercer Street Global Opportunity Fund LLC, a fund managed by Mercer Street Capital Partners. Under the terms of the facility, MGC will issue Mercer 586,432 convertible notes with a face value of USD1.0 each. The company said the funding will be used as working capital for "ongoing operations", including its clinical trials programme.

Read more
5 Dec 2022 14:09

IN BRIEF: MGC Pharmaceuticals delivers USD1 million order of ArtemiC

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Completes the delivery of its "largest" order of ArtemiC Rescue to US distribution and marketing partner, AMC Holdings Inc. Says the order is worth USD1.0 million and was delivered in a single shipment.

Read more
17 Nov 2022 15:48

UK shareholder meetings calendar - next 7 days

Friday 18 November 
MJ Gleeson PLCAGM
Just Eat Takeaway.com N.V.EGM
Marula Mining PLCAGM
NIOX Group PLCGM share premium account cancellation
Sovereign Metals LtdAGM
Monday 21 November 
Manchester & London Investment Trust PLCAGM
Mountview Estates PLCGM re re-electing Chair Powell, non-exec Archibald
RPS Group PLCGM cash offer agreement
Yamana Gold IncGM Gold Fields offer
Tuesday 22 November 
Alpha FX Group PLCGM re name change
Artemis Resources LtdAGM
Fonix Mobile PLCAGM
Kingswood Holdings LtdAGM
Origin Enterprises PLCAGM
Physiomics PLCAGM
Quantum Exponential Group PLCAGM
Rainbow Rare Earths LtdAGM
Sabien Technology Group PLCAGM
Town Centre Securities PLCAGM
Wednesday 23 November 
Crystal Amber Fund LtdAGM
CVS Group PLCAGM
Fidelity Asian Values PLCAGM
Genus PLCAGM
JPMorgan Russian Securities PLCGM re name change
Synergia Energy LtdAGM
Wilmington PLCAGM
Woolworths Holdings LtdAGM
Thursday 24 November 
Cloudbreak Discovery PLCAGM
EnSilica PLCAGM
Fiske PLCAGM
MGC Pharmaceuticals LimitedAGM
Pacific Horizon Investment Trust PLCAGM
Pan African Resources PLCAGM
PZ Cussons PLCAGM
Zanaga Iron Ore Co LtdAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
4 Oct 2022 11:07

IN BRIEF: MGC Pharmaceuticals appoints Yifat Steuer deputy CEO

MGC Pharmaceuticals - Perth, Australia-based medicinal cannabis company - Appoints Yifat Steuer as the company's new chief operating officer and deputy chief executive officer. Steuer has worked across a range of pharmaceutical companies, including Johnson & Johnson, GSK PLC as well as with start-ups. The company said that Brett Mitchell has moved from executive chair to non-executive chair "to be more in line with corporate structuring of UK listed companies."

Read more
28 Sep 2022 16:05

UK shareholder meetings calendar - next 7 days

Thursday 29 September 
ActiveOps PLCAGM
Chill Brands Group PLCAGM
Coral Products PLCAGM
Echo Energy PLCGM re approval of annual report
Jaywing PLCGM re funding
Orient Telecoms PLCAGM
President Energy PLCGM proposed capital reorganisation
Samarkand Group PLCAGM
TransGlobe Energy CorpGM re merger with Vaalco Energy Inc
Ted Baker PLCGM re shareholders vote on acquisition by ABG 
Vaalco Energy IncGM re merger with TransGlobe Energy Corp
Van Elle Holdings PLCAGM
Walker Crips Group PLCAGM
Friday 30 September 
Capital Metals PLCAGM
Henderson Smaller Companies Investment Trust PLCAGM
Ince Group PLCAGM
Indivior PLCGM additional US listing
Insig AI PLCGM financial outcomes
Libertine Holdings PLCAGM
MiLOC Group LtdAGM
Oakley Capital Investments LtdAGM
OptareAGM
Pennpetro Energy PLCAGM
Saietta Group PLCAGM
TMT Acquisition PLCAGM
TPXimpact Holdings PLCAGM
Versarien PLCAGM
Monday 3 October 
Jupiter Emerging & Frontier Income Trust PLCGM re amending redemption facility
Kape Technologies PLCGM re fundraise
Tuesday 4 October 
Henderson Diversified Income TrustAGM
Wednesday 5 October 
Goodwin PLCAGM
Hambro Perks Acquisition Co LtdAGM
MGC Pharmaceuticals LtdGM convertible securities agreement
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
28 Sep 2022 12:23

MGC Pharmaceuticals shares down on advertising fine in Australia

(Alliance News) - MGC Pharmaceuticals Ltd on Wednesday said it faces 23 infringement notices worth AUD306,960, around GBP185,470, for contravening therapeutic goods advertising laws.

Read more
23 Sep 2022 13:43

IN BRIEF: MGC Pharma receives USD550,000 more from Mercer Street

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Receives a further USD550,000 under the USD10 million financing agreement signed with Mercer Street Global Opportunity Fund LLC, a fund managed by Mercer Street Capital Partner. Under the terms of the agreement, announced in July, MGC Pharma will now issue Mercer 605,000 convertible notes with a face value of USD1.00 each. The funds received will be used to fund MGC's ongoing operations such as clinical trials.

Read more
21 Sep 2022 17:53

IN BRIEF: MGC notes "encouraging" results from CimetrA study

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says interim results from the CimetrA study show no significant Covid-19 related complications, compared to 63% of placebo group who reported adverse events related to Covid-19 symptoms. The study had 16 participants with Covid-19. No patients from either drug study group showed any Covid-19 related adverse events, it noted. It also notes improvements in multiple parameters measuring the patient's clinical condition, such as respiratory rate and oxygen saturation, when compared to placebo.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.